University of California, San Diego Moores Cancer Center
Clinical research site in La Jolla, California · 9300 CAMPUS POINT DR, LA JOLLA, CA 92037-1300 · (858) 657-7000
As of September 2026, 36 paid clinical trials are recruiting at University of California, San Diego Moores Cancer Center in La Jolla, California. Active studies at this site cover conditions such as Advanced Solid Tumor, Cervical Cancer and Metastatic Castration-resistant Prostate Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at University of California, San Diego Moores Cancer Center (36)
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Neoadjuvant Nivolumab + Relatlimab (Opdualag) Versus Nivolumab for Resectable High-Risk Basal Cell Carcinoma
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Retifanlimab and Ruxolitinib In Solid Malignancies
Perioperative Fostamatinib With Gemcitabine and Nab-paclitaxel in Resectable Pancreatic Cancer
Flow and Grow - The Ideal Time to Wean CPAP Off In Extremely Low Birth Weight Infants
ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES
Effect of Dupilumab on the Muscle Function of the Esophagus (food Pipe) in Participants with Eosinophilic Esophagitis (EoE)
Get new-trial alerts for University of California, San Diego Moores Cancer Center
We'll email you whenever a new clinical trial starts recruiting at this research site in La Jolla, CA. Unsubscribe anytime.
More research sites in La Jolla
- UC San Diego Moores Cancer Center (82 trials)
- University of California San Diego (58 trials)
- University of California, San Diego (51 trials)
- UC San Diego (16 trials)
- Scripps Health (13 trials)
- UCSD Moores Cancer Center (12 trials)
- UC San Diego Health (10 trials)
- Altman Clinical and Translational Research Institute (6 trials)
- Clinical Trial Site (6 trials)
- UCSD (6 trials)
Is this your research site?
This page is built from public ClinicalTrials.gov records. If you work here, we can correct it, send you the patients who apply, and build you a free website from your real studies — verify it with your work email, or read what we do for research sites.
Explore more
Paid clinical trials in La Jolla, CA · California clinical trials